Top
×
Cancer Drug Resist 2018;1:198-9.10.20517/cdr.2018.29© The Author(s) 2018.
Open AccessEditorial

Acknowledgement to reviewers of Cancer Drug Resistance in 2018

See all authors and affiliations

OAE Publishing Inc., Chaoyang District, Beijing 100027, China.

Correspondence Address: OAE Publishing Inc., Suite 601, Tower A, TYG Center, C2 North Road, East 3rd Ring Road, Chaoyang District, Beijing 100027, China. E-mail: editorial@cdrjournal.com

    Science Editors: Godefridus J. Peters, Aamir Ahmad | Copy Editor: Cai-Hong Wang | Production Editor: Huan-Liang Wu
    ...

    © The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

    The editors of the Cancer Drug Resistance would like to take this opportunity to express their sincere gratitude to the reviewers and guest editors for assessing manuscripts in 2018 [Table 1].

    Table 1

    Names of reviewers and guest editors

    Names
    Amstutz, UrsulaJansen, Gerrit
    Ahmad, AamirJiang, Zhao
    Balboni, BeatriceJoerger, Markus
    Ciriza, JesúsKwok, Hang Fai
    Cloos, JacquelineLink, Wolfgang
    Del Re, MarziaMarchesi, Federica
    El Hassouni, BtissameMatsuura, Yoshiyuki
    Fenton, TimMichaelis, Martin
    Fiandalo, MichaelMini, Enrico
    Firuzi, OmidNobili, Stefania
    Gan, BoyiNowak-Sliwinska, Patrycja
    Garajová, IngridPasternak, Amy
    Garrett, MichellePerego, Paola
    Giovannetti, ElisaPhillips, Roger M
    Gong, LiPore, Milind
    Griffiths, ElizabethRodriguez, Jose Antonio
    Huang, ShiliangRosière, Rémi
    Huisman, M.C.Wass, Mark
    Hussain, SulemanZaffaroni, Nadia

    Declarations

    Authors’ contributions

    Writing and revision of the article and approved the final version: Cancer Drug Resistance Editorial Office

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    None.

    Conflicts of interest

    All authors declared that there are no conflicts of interest.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    © The Author(s) 2018.

    Article Access Statistics

    • Viewed: 67
    • Downloaded: 9
    • Cited: Crossref0

    See Updates

    Table of Contents